Market research
002693.SHE Hainan Shuangcheng Pharmaceuticals Co., Ltd
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 4B
- P/E ratio
- 117.62
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.48
Community
Investor discussion
1 comment
Sign in to join the 002693.SHE discussion.
5 years, 4 months ago
Hainan Shuangcheng Pharmaceuticals Co., Ltd is currently in a long term downtrend where the price is trading 3.9% below its 200 day moving average.
From a valuation standpoint, the stock is 35.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.2.
Hainan Shuangcheng Pharmaceuticals Co., Ltd's total revenue sank by 0.9% to $76M since the same quarter in the previous year.
Its net income has dropped by 118.6% to $-9M since the same quarter in the previous year.
Finally, its free cash flow grew by 90.9% to $15M since the same quarter in the previous year.
Based on the above factors, Hainan Shuangcheng Pharmaceuticals Co., Ltd gets an overall score of 2/5.